echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Qilu Pharmaceutical Co., Ltd. completed the water needle freeze-drying preparation workshop in 50 days

    Qilu Pharmaceutical Co., Ltd. completed the water needle freeze-drying preparation workshop in 50 days

    • Last Update: 2017-02-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network enterprise news] it is reported that Qilu pharmaceutical has recently built a workshop for the production of water needle lyophilized preparations, with an annual capacity expected to achieve 5 million water needle preparations and 10 million freeze-dried powder needle preparations The project was started on December 1, 2016 and completed on January 19, 2017, lasting for 50 days (Qilu pharmaceutical took 50 days to build the water needle freeze-dried preparation workshop photo source: Baidu photo) on February 4, the reporter learned from Qilu Pharmaceutical (Hainan) company that Qilu pharmaceutical took 50 days to build the water needle freeze-dried preparation workshop, and the annual production capacity is expected to achieve 5 million water needle preparations and 10 million freeze-dried powder needle preparations This is a high-tech zone investment project for Qilu pharmaceutical, with a total investment of 70 million yuan The project was started on December 1, 2016 and completed on January 19, 2017, lasting for 50 days With the completion of the workshop, many products of Qilu group will be transferred to Hainan for production, and the Research Institute of Qilu group will also have multiple products developed and declared in the workshop In May 2016, Qilu pharmaceutical signed a framework cooperation agreement with the high tech Zone to accelerate development The project of more than 60 million yuan liposome nanoparticle production line was completed and put into production in 2016, filling the gap of nanotechnology manufacturing of anti-tumor drugs in Hainan Province According to statistics, in 2016, Qilu pharmaceutical realized sales revenue of more than 3.8 billion yuan and turned in taxes of more than 320 million yuan At present, the company is aiming at foreign markets, developing high-tech, high value-added anti-tumor drugs, and will strive to develop new drugs with independent intellectual property rights In 2017, Haikou high tech Zone will continue to issue industrial support policies to implement "one enterprise one policy" for leading enterprises And continue to provide services for key enterprises and projects in the park, use scientific and technological innovation to promote the supply side reform of the park, and promote the medical and health industry in Hainan to a new level.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.